Growing Demand for Scratch-resistant Glass: Market Expansion Driven by Mobile Devices and Automotive Applications

Scratch-resistant Glass Market
Scratch-resistant Glass Market

The scratch-resistant glass market is expected to be valued at USD 2.8 billion in 2024. The market’s progress is projected to be invigorating from 2024 to 2034, with a CAGR of 9.7%, compared to 2.5% in 2023. By 2034, the market value is forecasted to reach USD 7 billion.

With the increasing popularity of advanced and expensive smartphones and other mobile devices, consumers are becoming more concerned about safeguarding their investments. To protect their phone screens from scratches and other types of damage, scratch-resistant glass has become a popular choice among consumers.

The trend toward larger screens has also contributed to the demand for scratch-resistant glass. As screens have grown bigger, they have become more vulnerable to damage, creating a need for products that can protect them from scratches and other types of damage.

Consumer demand has led to the adoption of scratch-resistant glass in other industries, such as the automotive industry, where it is being used in windshields and windows to prevent damage from road hazards. As a result, there is a rising need for durable and long-lasting products in a wide range of industries, including eyewear and industrial applications. With the advancement of technology and the increasing reliance on electronic devices, the demand for scratch-resistant glass is expected to continue to grow in the future.

The production of scratch-resistant glass is quite expensive due to the intricate manufacturing process involved. This results in relatively higher prices for scratch-resistant glass products, which may make them less attractive to budget-conscious consumers. Furthermore, during the anticipated period, the market for scratch-resistant glass is expected to face tough competition from alternative materials such as plastic and polycarbonate.

“The rising demand for high-quality materials is reshaping the scratch-resistant glass market, especially in the electronics industry, where screens need protection against scratches and cracks. This type of glass is increasingly sought-after due to its ability to safeguard devices from damage, translating to enhanced durability and longer lifespans. This trend indicates a significant shift towards prioritizing longevity and performance, driving further growth in the scratch-resistant glass sector,” says an analyst at FMI.

Key Takeaways from the Scratch-resistant Glass Market

  • The scratch-resistant glass market is estimated to register a CAGR of 9.7%, with a valuation reaching US$ 7 billion by 2034.
  • Chemically strengthened glass is anticipated to dominate the market by registering a 9.5% market CAGR from 2024 to 2034.
  • With a 9.3% market CAGR, smartphones and tablets are likely to drive the market from 2024 to 2034.

Competitive Landscape

In the scratch-resistant glass sector, there is a broad spectrum of players offering a variety of solutions. Some companies present coatings or films that can be applied to surfaces, enhancing scratch resistance. On the flip side, others concentrate on creating innovative materials with inherent scratch-resistant properties. Additionally, there are specialized companies that excel in providing repair services for scratched surfaces. The market is dynamic, swiftly evolving, and expanding, with frequent introductions of new innovations and advancements.

Recent Developments in the Scratch-resistant Glass Market

  • In 2021, Corning Incorporated unveiled a fresh range of its tough, scratch-resistant glass composite products, namely Corning Gorilla Glass with DX and Corning Gorilla Glass with DX+.
  • In 2022, the latest addition to AvanStrate Inc.’s (ASI) product portfolio is the AvanRhino Cover Glass. It is designed with exceptional ability to withstand drops and scratches and can be used in various devices such as smartphones, laptops, tablets, and automobile monitors.
  • In 2023, PGT Innovations made Diamond Glass the standard glass in its WinDoor product portfolio. Diamond Glass is a type of laminated glass that is ultra-lightweight and features Corning Architectural Technical Glass. This glass is up to 45% lighter than traditional laminated glass and more than three times more resistant to scratches.

Top Key Players

  • Saint-Gobain S.A.
  • Corning Incorporated
  • Asahi Glass Co., Ltd.
  • Nippon Electric Glass Co., Ltd.
  • Schott AG
  • Guardian Industries
  • Kyocera Corporation
  • Murata Manufacturing Co., Ltd.
  • Rubicon Technology
  • Crystalwise Technology Inc.

Access the Complete Report for a Comprehensive Overview!

Scratch-resistant Glass Market Segmentation

By Product:

  • Chemically Strengthened Glass
  • Sapphire Glass

By Application Type:

  • Smartphones & Tablets
  • Automotive
  • Interior Architecture
  • Electronics
  • Others

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia
  • Europe
  • Oceania
  • MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Vaccines Market to Experience Robust Growth with a Projected to reach USD 80.8 billion by 2033

The global vaccines market is poised for extraordinary growth, with projections indicating a Compound Annual Growth Rate (CAGR) of 6.6%. This anticipated expansion will elevate the market from its 2023 valuation of USD 42.7 billion to an impressive USD 80.8 billion by 2033. This surge underscores the global commitment to preventive healthcare and the increasing adoption of immunization initiatives.

As a frontrunner in the healthcare sector, FMI (Future Market Insights) is strategically positioned to leverage this transformative growth. Our steadfast dedication to innovation and public health advancement places us at the forefront of groundbreaking developments in vaccine research, development, and distribution.

FMI’s strategic approach aligns with our overarching goal of contributing to a healthier future for individuals and communities worldwide. Our relentless pursuit of excellence in vaccine technology and public health initiatives reaffirms our role as a key player in shaping the future of global healthcare.

Driving Forces Behind Market Expansion:

  1. Groundbreaking Advancements in Vaccine Technology: Continuous innovation in vaccine research is paving the way for more effective and targeted solutions.
  2. Rising Demand for Preventative Healthcare: Growing awareness of preventive measures is driving a shift towards proactive healthcare solutions, with vaccines at the forefront.
  3. Global Focus on Immunization Efforts: Enhanced collaboration among governments, healthcare organizations, and NGOs is amplifying global immunization initiatives.

FMI recognizes the immense potential of the vaccines market and is committed to playing a vital role in its growth. Through our strategic partnerships and unwavering dedication to innovation, we aim to:

  • Support the Development of Next-Generation Vaccines: We will actively collaborate with stakeholders to accelerate the development and delivery of life-saving vaccines.
  • Enhance Vaccine Accessibility: We advocate for equitable distribution, ensuring that global populations have access to these crucial preventive measures.
  • Champion Preventative Healthcare Solutions: We will continue to promote the significance of vaccination as a cornerstone of public health.

FMI stands at the forefront of this exciting trajectory, dedicated to shaping a healthier future through the power of vaccines. As we move forward, we invite all stakeholders to join us in this vital mission to enhance global health through vaccination.

Expanding Market Need: Access Our Full Report for In-Depth Analysis and Trends!

Key Points:

  • The United States market leads the space in terms of market share. The market is anticipated to cross a value of USD 31.4 billion by 2033. The regional market is expected to thrive at a CAGR of 6.6% between 2023 and 2033.
  • The China market is leading in terms of CAGR. It thrives at a steady CAGR of 8.9% during the forecast period. The market is likely to reach a value of USD 6.0 billion by 2033. The origin of Covid-19 and enhanced healthcare structure are fuels for regional growth.
  • Subunit and conjugate are likely to thrive in the Vaccines type category due to their safer and more effective use. It is expected to thrive at a CAGR of 7.3% during the forecast period.
  • The injectable segment tops the end user tally with a CAGR of 6.7% between 2023 and 2033. The growth is attributed to easy and efficient implementation along with higher effectiveness.

Key Contributors to the Vaccines Market:

  • Merck & Co., Inc
  • GlaxoSmithKline
  • Pfizer BioNTech
  • Sanofi SA
  • CSL Limited
  • Emergent Biosolutions Inc.
  • Johnson & Johnson (J&J)
  • AstraZeneca plc
  • Bavarian Nordic A/S
  • Mitsubishi Tanabe Pharma Corporation.
  • Out of these GSK
  • Pfizer
  • Mark
  • Sanofi

For Instance:

  • In 2023, Sanofi SA is likely to launch a blood disorder drug for a rare bleeding disorder hemophilia.
  • Pfizer BioNTech introduced its booster shots as a third primary series dose for kids of 5 years of age that are diagnosed with certain kinds of immuno-compromise.

Key Segments:

By Vaccines Type:

  • Inactivated
  • Live attenuated
  • Recombinant
  • Toxoid
  • Subunit & Conjugate

By Valance:

  • Monovalent
  • Multivalent

By Route of Administration:

  • Injectable
  • Oral

By Indication:

  • Influenza
  • Pneumococcal Diseases
  • Human Papillomavirus
  • Meningococcal Diseases
  • Rotavirus
  • MMR
  • Hepatitis
  • DTP
  • Polio

By Distribution Channel:

  • Hospital Pharmacies
  • Institutional Sales
  • Retail Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Veterinary Infectious Disease Diagnostics Market Set to Exceed USD 4.9 Billion by 2033, Driven by Technological Advancements and Industry Commitment | FMI

The global veterinary infectious disease diagnostics market, valued at USD 1.9 billion in 2023, is poised for remarkable growth, with projections indicating it will surpass USD 4.9 billion by 2033. This expansion, as detailed in a recent analysis by Future Market Insights (FMI), reflects a robust compound annual growth rate (CAGR) of 10.1% over the forecast period.

Advancements in diagnostic technologies are central to this growth trajectory. Leading players in the industry are dedicated to enhancing customer experiences through the integration of artificial intelligence (AI) algorithms. These innovations provide veterinarians with cost-effective access to expert-level diagnostic insights, enabling remote specialist evaluations and post-diagnostic consultations. This commitment ensures that veterinary professionals can make comprehensive and timely medical decisions, ultimately benefiting animal healthcare.

“Our commitment is to empower veterinarians as our partners in animal healthcare,” stated a representative from FMI. “We tailor our solutions to seamlessly integrate into existing protocols, enhancing diagnostic precision and treatment efficacy across diverse therapeutic segments.”

Key offerings in this evolving market include advanced veterinary microbiology solutions designed for veterinary laboratories. These encompass high-quality culture mediums, identification tools, susceptibility testing items, and automated instruments and reagents for Johne’s Disease. These innovations cater to a wide range of species treated in veterinary medicine, supported by a vast array of pharmacological, biological, nutritional, and diagnostic products.

As the market continues to grow, FMI remains dedicated to providing insights that facilitate the development of cutting-edge solutions for veterinarians worldwide. This growth not only represents a significant advancement in veterinary diagnostics but also underscores the critical role that technology plays in improving animal healthcare outcomes.

Key Takeaways:

  • During the anticipated period, the United States is anticipated to lead the global veterinary infectious disease diagnostics market. In the United States, veterinary diagnostics are meant to assist veterinarians utilize medicines wisely, while also developing methods to combat animal diseases and zoonoses.
  • Japan is predicted to dominate the Asia Pacific veterinary infectious diseases diagnostics market throughout the forecast period. In order to improve animal health, major firms in Japan are offering diagnostic services using modern technology to identify novel ailments, particularly exotic diseases. In response to requests from the national and local governments of Japan, this is carried out.
  • Owing to its increasing sales and the rising occurrence of animal illnesses, the “immunodiagnostics” technology type is expected to hold the greatest revenue through the forecast period.
  • As pet popularity increases and pet insurance becomes more widely used, the “companion animal” animal type, and is the most creative segment for key companies, accounting for a sizable portion.

Heightened Demand for Market Data: Our Full Report Provides Extensive Trend Analysis!

Competitive Landscape:

The global veterinary infectious disease diagnostics market share is fragmented as a result of both domestic and international competitors. Several companies command substantial market shares in their respective specialty areas. Large corporations generally give natural events like product approvals and the rise in pet adoption around the world a significant amount of importance. The market for veterinary infectious disease diagnostics is predicted to expand quickly as a result of these factors.

Key Players:

  • Zoetis Inc.
  • Thermo Fisher Scientific
  • Virbac
  • Biomerieux SA
  • Heska Corporation
  • IDvet
  • NEOGEN Corporation
  • QIAGEN N.V.
  • Randox Laboratories Ltd.

Recent Developments:

  • In September 2018, Equine Progesterone, a test for determining the progesterone level in horses, was released, according to Eurolyser Diagnostica GmbH.
  • In January 2019, the Catalyst One and Catalyst Dx analyzers, an in-house testing technique for the measurement of progesterone levels in dogs, were launched by IDEXX Laboratories, Inc.

Key Segments Profiled in the Veterinary Infectious Disease Diagnostics Market Survey:

By Technology:

  • Immunodiagnostics
  • Molecular Diagnostic
  • Others

By Animal Type:

  • Companion Animal
  • Food-producing Animals

By End User:

  • Reference Laboratories
  • Veterinary Hospitals & Clinics
  • Point-of-Care
  • Research Institutes & Universities

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Lateral Flow Assays Market Set for Significant Growth, Projected to Reach USD 6.9 Billion by 2033

The global lateral flow assays market is poised for substantial growth, with projections indicating a surge to USD 6.9 billion by 2033, up from USD 4.3 billion in 2023. This forecast, detailed in the latest report by Future Market Insights (FMI), highlights a robust Compound Annual Growth Rate (CAGR) of 4.7% over the next decade.

Lateral flow assays, renowned for their efficacy as point-of-care tests, are experiencing heightened demand worldwide. These tests deliver swift and reliable results directly at the testing site, eliminating delays associated with laboratory sample processing. This rapid turnaround is pivotal in expediting diagnosis and treatment decisions, especially crucial in managing infectious diseases.

The escalating prevalence of infectious diseases globally underscores the critical need for efficient diagnostic solutions. Lateral flow assays offer a practical and user-friendly approach to early disease detection and management, significantly contributing to their escalating adoption.

With a growing emphasis on cost-effective diagnostic tools, lateral flow assays emerge as preferred options across diverse applications. Their affordability and simplicity make them indispensable in resource-limited settings, enhancing accessibility to crucial diagnostic capabilities.

Beyond healthcare, lateral flow assays find extensive application in veterinary diagnostics, food safety testing, environmental monitoring, and more. This versatility broadens their market penetration and adoption across multiple sectors, reinforcing their role as indispensable diagnostic tools.

The projected growth trajectory of the global lateral flow assays market underscores their pivotal role in meeting evolving healthcare demands and addressing emerging challenges. As the demand for rapid, reliable, and cost-effective diagnostic solutions continues to escalate, lateral flow assays are set to shape the future of diagnostics worldwide.

Key Takeaways:

  • The Kits & Reagents segment is anticipated to grow at a rapid CAGR of 5.3% during the forecast period.
  • The clinical testing segment accounted for 90.9% of the lateral flow tests market.
  • With a lateral flow tests market share of 70.9% in 2020, sandwich assays dominated the lateral flow tests market.
  • Blood samples were the most preferred, with a 53.1% lateral flow tests market share.
  • The hospitals and clinics segment was the most favoured, with a lateral flow tests market share of 37.6%.
  • China, the world’s second-largest economy, is expected to reach a lateral flow tests market size of USD917 million in 2027, with an annual growth rate of 8.8%.
  • Within Europe, Germany is expected to show a lateral flow tests market growth at a 4.8% compound annual growth rate (CAGR), while the rest of the European market will reach USD917 million by 2027.
  • The Asia Pacific region is expected to increase at a CAGR of 4.2% during the forecast period.

Rising Interest in Market Trends: Our Detailed Report Provides Essential Insights!

Competitive Landscape:

Some companies have increased their lateral flow tests market share through various strategies such as mergers and acquisitions. In contrast, others invent new diagnostic market test methods and provide innovative goods to maintain their market share.

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Biomérieux SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F Hoffmann-La Roche Ltd.
  • Merck
  • Quidel Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Key Segments Covered in the Market Report:

By Application:

  • Clinical Testing
  • Veterinary Diagnostics
  • Food Safety & Environmental Testing
  • Drug Development & Quality Testing

By Technique:

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

By Sample Type:

  • Blood Samples
  • Urine Samples
  • Saliva Samples
  • Others
  • By Type
  • Kits & Reagents
  • Lateral Flow Readers

By End User:

  • Hospitals & Clinics
  • Diagnostics Laboratories
  • Home Care Settings
  • Pharmaceuticals & Biotechnology Companies
  • Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Virology Specimen Collection Market Set for Resilience and Growth Despite Short-term Challenges | FMI

A new market report released today reveals that the global virology specimen collection market, valued at USD 5.6 billion in 2021, is poised for resilience and expansion over the next decade. Although the market faces challenges, including a projected negative Compound Annual Growth Rate (CAGR) of -0.5% from 2022 to 2032, steady growth is anticipated.

Key drivers for this growth include the rapid emergence of various viruses worldwide, which has led to increased prioritization of virus specimen collection by research institutes and healthcare sectors. Technological advancements in specimen collection processes are also playing a crucial role, significantly improving efficiency and fostering international collaboration for research purposes.

“The global landscape for virology specimen collection is evolving rapidly, driven by the urgent need for comprehensive data to combat emerging viral threats,” stated a FMI. “Our report underscores the critical role of advanced technology and international cooperation in shaping the future of virus research and containment efforts.”

Despite the projected decline in CAGR, the market’s trajectory reflects a strong commitment to enhancing global preparedness against viral outbreaks through systematic specimen collection and analysis. This strategic focus is expected to propel market growth amidst ongoing challenges.

The report further highlights the significance of innovation in virology specimen collection technologies, consumables, and instruments, especially in response to outbreaks such as the Zika virus and Babesia. These developments underscore the need for cutting-edge solutions in the field.

Moreover, initiatives undertaken by various countries to monitor and combat new and emerging diseases—coupled with the prevalence of diseases such as EBOLA, Zika virus, SARS-CoV-2, AIDS, flu, and STDs—are driving the growth of the virology specimen collection market.

Key Takeaways:

  • North America is anticipated to be at the forefront of the virology specimen collection market future trends, which can be attributed to the increasing adoption of NAT and technological advancements such as portable diagnostics.
  • The bacterial specimen collection segment is projected to lead the virology collection market trend by product type. The high prevalence of tuberculosis (TB) is one of the significant factors contributing to the share of the segment.
  • Diagnostic applications are expected to account for a significant portion of the virology specimen collection market size due to a spike in the number of FDA-approved specimen collection kits, transport of viral specimen, and virology swab sample for clinical applications.
  • By end use, the hospitals and clinics segment is anticipated to generate the most revenue, owing to an uptick in patients with respiratory viruses and bacterial infections.
  • The Asia Pacific market for bacterial and virology sample collection is expected to grow at a rapid pace because of extensive coronavirus testing in Asian countries.
  • By technology, the segment of the nasopharyngeal sample is estimated to hold sway on account of rapid detection of transmissible transfusion infections (TTIs) and the rising prevalence of HPV-related cancers and human papillomavirus (HPV).

Enhanced Market Demand: Discover Thorough Trends and Insights in Our Complete Report!

Competitive Landscape:

A few notable virology specimen collection market players include Puritan Medical Products Co. (UK), Trinity Biotech (Ireland), Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Vircell S.L. (Spain), Becton, Quidel Corporation (US), Titan Biotech Ltd. (India), Diasorin SA (Italy), Copan Italia S.P.A (Italy), Hardy Diagnostics (US).

These firms and companies are partnering & collaborating with several domestic and international players as a part of the emerging trends in the viral specimen collection market.

  • Henkel AG & Co. KGaA of Germany tied up with Origin of California to leverage the latter’s expertise in performing robust mechanical testing at its California facility. Henkel also contributed expertise and technology to developing 3D printed nasopharyngeal swabs for COVID-19 testing and several other recent developments in the virology specimen collection market.
  • Under a USD 6.0 million contract with Inflammatix Inc., the US HHS supported the development of the host-response testing technology. The company is working on three diagnostic tests that will provide quick results on whether the infection is bacterial or viral. This enables clinicians to make better-informed, earlier treatment decisions. Such initiatives are also at the heart of the companies’ strategy to expand earlier diagnosis.

Key Segments:

By Product Type:

  • Blood Collection Kits
  • Specimen Collection Tubes
  • Viral Transport Media
  • Swabs

By Sample:

  • Blood Samples
  • Nasopharyngeal Samples
  • Throat Samples
  • Nasal Samples
  • Cervical Samples
  • Oral Samples
  • Other Samples

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Drug Screening Market Set for Explosive Growth, Projected to Reach Over USD 32.4 Billion by 2033

The global drug screening market is on the brink of remarkable expansion, with projections indicating a robust compound annual growth rate (CAGR) of 16.1% from 2023 to 2033. Valued at USD 7.3 billion in 2023, the market is expected to surpass USD 32.4 billion within the next decade, driven by several critical factors enhancing the adoption of drug screening technologies worldwide.

Key drivers of this growth include the rising prevalence of drug consumption among adults and stringent regulations in Islamic countries that prohibit alcohol consumption. These factors are significantly fueling demand for advanced screening and testing technologies. Governments around the globe are increasingly embracing state-of-the-art screening equipment, recognizing its importance in maintaining public health and safety.

Innovations in high-throughput screening (HTS) and high-content screening (HCS) are reshaping the landscape of drug discovery, contributing to market enlargement. Furthermore, the rise of fragment-based drug discovery (FBDD), which focuses on low-complexity compounds or fragments, is accelerating market expansion.

Corporate sectors are also adopting drug testing and screening solutions to foster a safe and healthy workforce environment. Regulatory pressures are compelling businesses to implement stringent drug control measures, further driving the demand for enhanced screening solutions.

“The increasing misuse and trafficking of prescribed drugs underscore the urgent need for advanced drug screening technologies,” said FMI. “This market growth reflects a global commitment to combating substance abuse and ensuring workplace safety through cutting-edge screening solutions.”

As the global drug screening market continues to evolve, it is positioned for substantial growth driven by technological advancements and regulatory imperatives aimed at fostering a drug-free environment.

Key Points:

  • The United States market leads the space in terms of market share and CAGR. The market is anticipated to cross a value of USD 11.5 billion by 2033. The regional market is expected to thrive at a CAGR of 15.8% between 2023 and 2033.
  • The Chinese drug screening market is another significant market. It thrives at a steady CAGR of 15.4% during the forecast period. The market is likely to reach a value of USD 2.3 billion by 2033. The prevalence of drug consumption and stringent government policies are fueling the demand for drug screening.
  • Rapid testing devices are likely to thrive in the product and service type category due to faster and more efficient drug testing methods. It is expected to thrive at a CAGR of 15.8% during the forecast period.
  • The drug testing devices laboratories segment tops the end user tally with a CAGR of 15.4% between 2023 and 2033. The growth is attributed to higher consumption and lack of drug testing equipment in the organizations due to the lower awareness.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!

Competitive Landscape:

The key players focus on providing drug screening solutions at cheaper prices while making these products portable, efficient, and effective. Key competitors also merge, acquire, and partner with other companies to increase the supply chain and distribution channel. The key players in the market are: Laboratory Corporation of America Holdings, Hoffmann -La Roche Ltd, BioMerieux SA, Bio-Rad Laboratories Inc., Biomedical Diagnostics

For instance:

  • Bio-Rad Laboratories Inc has introduced its Bio-Rad which works on different concepts such as target discovery, lead discovery, preclinical research, and Progress development. This has extended the research and development programs for the brand.
  • BioMerieux SA has completed its 60 years in the service. This has resulted in the biomerieux and InDevR partnership of 5 million. This will be the exclusive distributor in Europe of VaxArray.

Major Contributors of the Drug Screening Market:

  • Laboratory Corporation of America Holdings,
  • Hoffmann -La Roche Ltd
  • BioMerieux SA
  • Express Diagnostics Int’l, Inc.
  • Bio-Rad Laboratories Inc.
  • Biomedical Diagnostics
  • Danaher
  • Synergy Health plc.
  • Agilent Technologies
  • Shimadzu Medical Pvt. Ltd.
  • Alere Inc.
  • Premier Biotech, Inc.
  • Psychemedics Corporation
  • Siemens Healthineers Private Limited
  • American Bio Medica Corporation
  • Sciteck, Inc.
  • ACM Global Laboratories.
  • CareHealth America
  • Clinical Reference Laboratory, Inc.

Key Segments:

By Sample Type:

  • Urine samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples

By Product and Service:

  • Drug screening
  • Analytical Instruments
  • Rapid Testing Devices
  • Consumables
  • Drug Screening Service

By End User:

  • Drug Testing Laboratories
  • Criminal Justice and Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools and Colleges
  • Workplaces

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Healthcare Interoperability Solutions Market Set to Expand at a CAGR of 14.5% by 2033

The global healthcare interoperability solutions market is on the brink of unprecedented growth, with projections indicating a remarkable compound annual growth rate (CAGR) of 14.5%. According to recent analysis, the sector is expected to surge from USD 4.2 billion in 2023 to an impressive USD 16.2 billion by 2033.

This significant growth is driven by several key factors, including governmental initiatives aimed at enhancing patient care and safety, a heightened focus on reducing healthcare costs, and increased government funding for interoperability solutions. Collectively, these elements are propelling the market’s expansion and reinforcing its vital role in transforming healthcare systems worldwide.

Healthcare interoperability solutions are essential for evaluating the effectiveness of pharmaceuticals and ensuring the seamless delivery of treatments to patients. This functionality is particularly vital for supporting public health programs and enhancing the overall efficiency of healthcare systems. As a result, demand for these solutions is expected to maintain a robust upward trajectory in the coming years.

In developed economies, the rising cost of healthcare underscores the necessity of efficient interoperability solutions. According to the Organization for Economic Co-operation and Development (OECD), public spending on healthcare and long-term care in these nations represented approximately 6% of GDP in 2018, with projections suggesting an increase to 9% by 2030 and 14% by 2060. This growing financial burden on healthcare systems is driving the need for innovative solutions that improve efficiency and reduce costs.

A recent survey by Future Market Insights highlights the immense growth potential within the global healthcare interoperability solutions market. The rising demand for comprehensive healthcare systems, coupled with the increasing adoption of interoperability solutions, will be instrumental in addressing evolving healthcare needs and improving overall system performance.

As the healthcare landscape continues to evolve, the adoption of advanced interoperability solutions will be essential in meeting the growing demand for efficient, cost-effective healthcare services worldwide.

Key Takeaways:

  • Digital advancements in the global healthcare interoperability solutions market offer video conferencing, interoperability software, and phonic conversations, propelling this market to a high growth stage. Healthcare interoperability technologies are expected to decrease the cost of delayed diagnosis and therapy by enabling real-time data access. The future of healthcare depends on sharing data throughout the value stream and integrating all medical devices.
  • At present, healthcare is focused on a curative care approach but data-driven technologies can change this into an exclusively preventive care paradigm, which will create a lucrative potential for the market.
  • The global market for healthcare interoperability solutions is predicted to develop over the assessment timeframe. With more IT systems installed around the globe are elevating the overall healthcare sector.
  • To digitize health data and processes, hospitals and healthcare organizations around the world are using healthcare IT solutions like EHR systems. The amount of data in electronic health records is propelling, making it challenging to store significant amounts of data securely without facing the risk of losing crucial data.
  • The amount of healthcare data within growing economies is further spreading to surge populations. Government attempts to install interoperable solutions, an increase in government spending on healthcare systems, and the growing acceptance of automation technology all together indicate to a significant growth opportunity for market players across these countries.

Enhanced Market Demand: Discover Thorough Trends and Insights in Our Complete Report!

Competitive Landscape:

The influx of new participants is expected to grow due to untapped opportunities, increasing competition in the healthcare interoperability solutions market.

  • In January 2022, Koninklijke Philips acquired Capsule Technologies, Inc. to transform healthcare delivery through integrated solutions.
  • In May 2021, Epic Systems and Anthem, Inc. teamed up to integrate Epic Systems’ Payer Platform into Anthem’s Health OS, aiming to reduce administrative burdens and bridge care gaps.

Recent developments in the healthcare interoperability solutions market have been closely monitored by the team at Future Market Insights, with detailed insights available in the full report.

Key players:

  • Allscripts Healthcare Solutions
  • Epic Systems Corporation
  • Cerner Corporation, Inc.
  • Infor, Inc.
  • Koninklijke Philips NV
  • Orion Health Group Limited,
  • Quality Systems, Inc.
  • OSP Labs,
  • ViSolve, Inc.
  • InterSystems Corporation
  • iNTERFACEWARE

More Insights into Healthcare Interoperability Solutions Market

The North American region is anticipated to dominate the global healthcare interoperability solutions market. The United States is predicted to account for around 35.3% of the global market in 2023.

Surging demand for effective healthcare services, the need to reduce healthcare costs, and successful EHR implementation by healthcare organizations are the main drivers influencing the adoption of interoperability solutions in the USA.

Germany is predicted to account for 4.9% of the global market share in 2023. The growth in the region is attributed to the better-built healthcare infrastructure for the incorporation of clinical data from patient care and information technology with medical research in Germany.

Key Segments Covered in Healthcare Interoperability Solutions Market Industry Research

By Type:

  • Solutions
    • EHR Interoperability
    • HIE Interoperability
    • Others
  • Services

By Level of Interoperability:

  • Foundational Interoperability
  • Structural Interoperability
  • Semantic Interoperability

By Deployment:

  • Cloud Based
  • On premise

By End User:

  • Healthcare Providers
  • Healthcare Payers

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Drug Discovery Services Market Poised for Transformative Growth, Projected to Reach USD 76.5 Billion by 2033

The global drug discovery services market is set to undergo a remarkable transformation, with an estimated valuation of USD 76.5 billion by 2033, according to a comprehensive market analysis released today. This projection indicates a substantial increase from the anticipated USD 19.7 billion valuation in 2023, reflecting an impressive compound annual growth rate (CAGR) of 14.5% over the next decade.

The driving force behind this significant growth is the escalating demand for innovative therapies to combat chronic diseases. As chronic illnesses become increasingly prevalent worldwide, the urgency for novel treatment solutions has intensified, creating a fertile landscape for advancements in drug discovery services.

“Investments in research and development (R&D) are surging, fueled by unmet medical needs across various therapeutic domains,” stated a representative from Future Market Insights (FMI). “This trend underscores a pivotal moment for the pharmaceutical sector, where innovation and technological advancements are crucial in meeting evolving healthcare challenges.”

Technological breakthroughs, particularly in mass spectrometry for oncology drug development, are revolutionizing the drug discovery process. These innovations not only enhance the efficiency of drug discovery but also accelerate the timelines for bringing new therapies to market, ensuring that patients have timely access to vital treatments.

The optimistic forecast for the drug discovery services market reflects a promising future driven by the convergence of escalating chronic disease burdens, unmet medical needs, and continuous technological innovations. The stage is set for exceptional growth and innovation in the years ahead, positioning the pharmaceutical industry as a vital player in addressing global health challenges.

Key Takeaways from Drug Discovery Services Market:

  • In 2022, the global drug discovery services market size stood at USD 17.5 billion.
  • The pharmaceutical companies segment accounted for 42% market share in 2022.
  • In terms of market share, the Hit-to-lead identification method is the dominant segment.
  • During the projection period, the biological services segment in the market is expected to increase at a high CAGR.
  • The oncology segment accounted for an impressive 39.7% market share in 2022.
  • North America accounted for a massive 35.2% market share in 2022.

Rising Interest in Market Trends: Our Detailed Report Provides Essential Insights!

Recent Developments Observed by FMI:

  • Genentech announced in January 2023 that it had been granted Priority Review and Fast Track designation for Glofitamab. To treat adult patients with refractory or relapsing LBCL, the medication, a new bispecific antibody, activates immune system T-cells.
  • Brexpiprazole, an atypical antipsychotic supplement NDA authorized for schizophrenia, was released in January 2023 under FDA Priority Review. Brexpiprazole was developed by H. Lundbeck A/S and Otsuka Pharmaceuticals.
  • The FDA approved UCB’s Rozanolixizumab for additional Phase III research in January 2023.
  • Harm Reduction Therapeutics announced about RiVive in December 2022. As the FDA accepted and awarded Priority for Review to their new drug application. The product is an over-the-counter nasal spray form of naloxone.

Key Players in the Market:

  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International Inc.
  • Genscript Biotech Corporation
  • Thermo Fisher Scientific Inc.
  • Pharmaron Beijing Co. Ltd.
  • Evotec SE
  • Eurofins Scientific SE
  • Pharmaceutical Product Development Inc.
  • Piramal Enterprise Limited
  • Syngene International Limited

Market Segmentation:

By Process:

  • Target Selection
  • Target Validation
  • Hit-to-lead identification
  • Lead Optimization
  • Candidate Validation

By Type:

  • Chemistry Services
  • Biology Services

By Drug Type:

  • Small Molecule Drugs
  • Biologics Drugs

By Therapeutic Area:

  • Neurology
  • Infectious and Immune Systems Diseases
  • Digestive System Diseases
  • Oncology
  • Other Therapeutic Areas

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes
  • Manufacturing
  • Other End Users

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Growth Prospects in the Water Treatment Chemical Market: Projected Valuation of USD 58 Billion by 2034

Water Treatment Chemical Market
Water Treatment Chemical Market

 

The water treatment chemical market is poised for substantial growth, projected to reach a valuation of USD 38.6 billion in 2024 and expand to USD 58 billion by 2034, reflecting a compound annual growth rate (CAGR) of 4.2%. This growth underscores the vital role that water treatment chemicals play in ensuring the safe and efficient purification of water for both industrial and domestic applications. As global demand for clean water continues to rise amid increasing environmental concerns and regulatory pressures, the industry presents significant opportunities for innovation and investment, catering to the urgent need for effective solutions in water treatment processes.

The demand for clean water and increasing awareness of water pollution drive market growth. Industrialization, technological advancements, and strict environmental laws in emerging nations also drive the development of the water treatment chemical market.

Population growth and industrial water demand drive the global market for water treatment chemicals. As water reuse and recycling become more important, industries recognize the importance of water. The rise in awareness of the negative effects of water pollution has increased the demand for water treatment chemicals. This demand for innovative solutions to protect water purity and ecosystems drives significant global market growth.

Advancements in water treatment techniques are driving the global expansion of the water treatment chemicals market, addressing pollution and water scarcity concerns. Industrialization also contributes to the demand for efficient water purification and treatment solutions, as water is crucial for various industrial processes. The need for effective solutions further underscores the importance of the industry.

The water treatment chemical industry is experiencing a surge in demand, especially in emerging economies, due to increasing awareness of waterborne diseases and the need for improved water quality. The industry has evolved to meet these demands, driven by population growth, industrialization, pollution awareness, and technological progress, shaping the future trajectory of the water treatment chemical market.

Key Trends Influencing the Water Treatment Chemical Market

The water treatment chemical market is experiencing significant changes driven by various trends and factors. Here are the key trends influencing the market:

1. Increased Water Scarcity

  • Growing global water scarcity due to climate change, population growth, and industrialization is pushing industries to invest in water treatment chemicals to improve water recycling and reuse practices.

2. Regulatory Compliance

  • Stricter regulations concerning water quality and environmental protection are compelling industries to adopt advanced water treatment solutions, leading to higher demand for effective treatment chemicals.

3. Emerging Contaminants

  • The rise of emerging contaminants, such as pharmaceuticals and personal care products, is prompting the development of innovative treatment chemicals that can effectively remove these pollutants from water sources.

4. Technological Advancements

  • Advancements in technology, including the use of smart monitoring systems and automated chemical dosing, are enhancing the efficiency and effectiveness of water treatment processes, thereby boosting the demand for specialized chemicals.

5. Shift Toward Sustainable Solutions

  • There is a growing preference for eco-friendly and sustainable water treatment chemicals. Companies are investing in research and development to create biodegradable and non-toxic alternatives, aligning with environmental sustainability goals.

6. Expansion of the Industrial Sector

  • The rapid expansion of various industrial sectors, particularly in developing regions, is increasing the demand for water treatment chemicals to meet operational needs and ensure compliance with environmental standards.

Uncover Extensive Insights with the Full Report!

Competitive Landscape of the Water Treatment Chemical Market

Innovations and strategic initiatives are transforming the global water treatment chemical sector. Innovations in materials, manufacturing techniques, and water treatment chemistry are pioneered by research and development centers inside water cleansing corporations.

Technological advancements are accelerated by cooperative relationships between government agencies, academic institutions, and industry participants. With their knowledge of large-scale hydro disinfection projects, pH adjusters and stabilizer technology, and water purification technologies, BASF SE, Ecolab Inc., and Solenis LLC are leading the industry. Their combined influence propels water treatment chemical solutions’ innovation, efficiency, and scalability. These qualities are all essential for the sector’s advancement toward broad acceptance and the switch to green hydropower generation.

The demand for water treatment chemicals is increased globally by these producers, promoting innovation, market expansion, and technical developments in the coming decade.

Key Companies in the Water Treatment Chemical Market

  • BASF SE
  • Ecolab Inc.
  • Solenis LLC
  • Akzo Nobel N.V.
  • Kemira OYJ
  • Suez SA
  • Dow Inc.
  • Lonza Group AG
  • Snf Floerger Group
  • Kurita Water Industries Ltd.
  • LG Chem Ltd.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Surgical Instruments Tracking Systems Market Set to Surge, Projected to Reach USD 940 Million by 2033

The global surgical instruments tracking systems market is on the rise, with projections indicating an impressive Compound Annual Growth Rate (CAGR) of 13.9% over the next decade. Valued at USD 255 million in 2023, the market is anticipated to reach an estimated USD 940 million by 2033. This growth is largely driven by the increasing volume of surgical procedures and the need to comply with stringent regulatory standards aimed at enhancing patient safety and operational efficiency.

As surgical interventions continue to rise globally, healthcare providers are under pressure to adopt advanced technologies for managing surgical tools. Inadequate handling of surgical instruments can lead to prolonged procedures, elevated infection risks, and increased costs. To address these challenges, healthcare facilities are increasingly turning to state-of-the-art surgical instruments tracking systems. These solutions facilitate the automation of identification, monitoring, and management of surgical instruments, ensuring compliance with the U.S. FDA’s Unique Device Identification (UDI) regulations.

“The growing demand for surgical instruments tracking systems is primarily fueled by the urgent need to enhance surgical safety amid rising surgical volumes,” stated a representative from Future Market Insights (FMI). “These systems reduce the risks associated with manual tracking, streamline inventory management, and optimize resource allocation.”

Several key factors support the market’s expansion, including a global increase in surgical procedures and rising demand for efficient inventory control systems. By utilizing advanced technologies such as Radio-Frequency Identification (RFID) and barcode scanning, these tracking systems offer real-time monitoring, significantly reducing equipment loss and ensuring that sterile instruments are readily available when needed.

As the healthcare sector continues to prioritize patient safety and operational efficiency, the adoption of surgical instruments tracking systems is expected to become essential in modern surgical environments. These systems promise to not only improve patient outcomes but also enhance operational workflows across healthcare facilities worldwide.

Key Takeaways:

  • The global surgical instruments tracking system market is expected to be dominated by the United States during the estimated period. The Centers for Disease Control and Prevention (CDC) estimate that hospital-acquired illnesses claim the lives of roughly 90,000 Americans annually. The market for surgical instrument tracking systems is being driven by the desire to reduce infection brought on by contaminated tools as well as the requirement for better inventory management.
  • During the forecast period, China and Japan are anticipated to dominate the Asia Pacific surgical tools tracking system market. The production of technologically advanced software and hardware solutions is also anticipated to encourage the use of surgical tool tracking systems in these countries over the projected period. Moreover, leading companies in these countries provide complete, high-quality surgical instruments for all surgical specialties.
  • Owing to its affordable cost of installation and ease of adoption by the leading players in the market, the barcode technology is expected to hold the greatest revenue, through the forecast period.
  • As it utilizes technology more frequently than conventional clinics or other healthcare facilities, the hospital is the most lucrative segment for key companies, accounting for a sizable portion.

Boosted Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report!

Competitive Landscape:

The surgical instruments tracking systems market share is fragmented as a result of both domestic and international competitors. Several companies command substantial market dominance in their respective specialty areas. Large corporations often give natural events like product approvals, the possibility of accidents, and misplaced surgical equipment a high priority. These elements are anticipated to propel the surgical instruments tracking system market to expand rapidly.

Key Players:

  • SpaTrack Medical Limited
  • Keir Surgical Ltd.
  • NuTrace
  • Vizinex RFID
  • ScanCARE Pty Ltd.
  • RFID Discovery
  • Healthtech Pivot LLP
  • RMS Omega Healthcare
  • Avery Dennison Corporation
  • Becton, Dickinson and Company
  • STERIS
  • Integra LifeSciences Holdings Corporation
  • Xerafy
  • B. Braun Melsungen AG.

Key Segments Profiled in the Market Survey:

By Component:

  • Software
  • Hardware
  • Services

By Technology:

  • Barcode
  • Radio Frequency Identification (RFID)

By End User:

  • Hospital
  • Public Hospital
  • Private Hospital
  • Others

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East &Africa
  • Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube